Zymeworks Inc (NAS:ZYME) Stock News, Headlines & Updates
Zymeworks Inc Stock News from GuruFocus
- 1
Jul 11, 2024
Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024
Marketwired • 6:00am
Jun 17, 2024
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers
Marketwired • 5:00am
Jun 10, 2024
Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract Cancer
Marketwired • 5:00am
May 28, 2024
Zymeworks Announces Participation in Upcoming Investor Conferences
Marketwired • 6:00am
May 16, 2024
Kirby McInerney LLP is Investigating Potential Shareholder Claims Against Zymeworks Inc. (ZYME)
Business Wire • 4:00pm
May 07, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
PRNewswire • 7:00pm
May 03, 2024
Zymeworks Inc (ZYME) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and Advancing Clinical Trials
GuruFocus Research • 2:07am
Q1 2024 Zymeworks Inc Earnings Call Transcript
GuruFocus Research • 11:23pm
May 02, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
Marketwired • 4:00pm
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
Marketwired • 4:00pm
Apr 30, 2024
Zymeworks Announces Participation in Upcoming Investor Conferences
Marketwired • 5:00am
Apr 28, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
PRNewswire • 9:00am
Apr 24, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
Marketwired • 3:00pm
Apr 20, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news